IPL and dry eye

Conference|Twin Cities Ocular Surface Disease Symposium

Ahmad Fahmy, OD, FAAO, DIPL, ABBO, highlights intense pulsed light (IPL) therapy for the treatment of ocular surface disease at the second annual Twin Cities Ocular Surface Disease Symposium in Minneapolis.

Related: Ahmad Fahmy checks in at the Twin Cities Ocular Surface Disease Symposium 2019

Related Videos
Related Content

This week in optometry: March 10-March 16

March 17th 2023

Debunking common ortho-k myths

October 6th 2022

Artificial tear ingredients that mimic the real thing

March 14th 2023

Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

September 24th 2021

First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease

March 2nd 2023

CooperVision’s MyDays Energys contact lenses hit US market

March 1st 2023

This week in optometry: March 10-March 16

March 17th 2023

Debunking common ortho-k myths

October 6th 2022

Artificial tear ingredients that mimic the real thing

March 14th 2023

Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

September 24th 2021

First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease

March 2nd 2023

CooperVision’s MyDays Energys contact lenses hit US market

March 1st 2023

This week in optometry: March 10-March 16

March 17th 2023

Debunking common ortho-k myths

October 6th 2022

Artificial tear ingredients that mimic the real thing

March 14th 2023

Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

September 24th 2021

First patient enrolled in pivotal phase 3 clinical trial of BRM421 for dry eye disease

March 2nd 2023

CooperVision’s MyDays Energys contact lenses hit US market

March 1st 2023
© 2023 MJH Life Sciences

All rights reserved.